SATB1 and prostate carcinoma: Aberrant expression of SATB-1 has been reported in cells of various cancer types, including prostate cancer, ovarian cancer, gastric cancer, hepatocellular carcinoma, renal cell carcinoma, rectal cancer, bladder cancer, laryngeal squamous cell carcinoma, and cutaneous malignant melanoma29,30.